COVAXIN, India's First COVID-19 Vaccine Candidate, Set For Phase I, II Human Trials

(58)

Covaxin phase-3 trial will begin as second trial has successful results | India | Corona Vaccine

(1:12)

COVAXIN Phase-II Human Trials To Begin In September | Breaking News

(26)

Coronavirus Updates: Phase 2 Trial Of Covaxin To Begin In September

(1:24)

COVID-19 Crisis: Phase-II Human Trials For Bharat Biotech's COVAXIN Vaccine To Commence In September

(3:7)

Covaxin Phase 1 Trial Clears Lancet Review, Phase 3 Trial Ongoing

(9:11)

Bharat Biotech Covaxin phase III trial is approved by Subject Expert Committee with 77.8% efficacy

(1:44)

Bharat Biotech releases Covaxin's price ahead of India's phase 3 of vaccination | COVID-19 Vaccine

(2:54)

Covid-19 Vaccine: Covaxin Phase 3 Trial Data Shared With Expert Panel Which Meets Today

(2:17)

Bharat Biotech Phase 3 Results | Covaxin releases their interim analysis from phase three trials

(3:36)

Bharat Biotech Enrols Over 25,000 Volunteers For Covaxin Phase 3 Trial

(2:23)

Bharat Biotech's Dr Krishna Ella On Efficacy Of Covaxin, Side Effects \u0026 Nasal Vaccine | Newstrack

(48:39)

‘Covaxin has 81% efficacy’: Bharat Biotech phase 3 trial results

(2:32)

COVID-19 Vaccine: Efficacy vs Effectiveness

(8:6)

Bharat Biotech announces Covaxin's efficacy rate after final stage trials | COVID-19 Vaccine | News

(2:14)

Bharat Biotech's Covaxin Shows 77.8% Efficacy Rate In Phase 3 Trial

(4:56)

Bharat Biotech's Covaxin Recommended By Expert Panel For Phase 2/3 Trials On Children

(3:52)

Bharat Biotech Announces Phase 3 Results of Covaxin, Says It Shows Interim Efficacy of 81%| Breaking

(1:5)

Covaxin Shows 77% Efficacy In Phase 3 Trials, Bharat Biotech Informs Govt Panel, Data Under Review

(2:31)

Covaxin 77.8% Effective In Phase 3 Trial Data: Sources

(2:55)

Covaxin shows 77.8% efficacy in phase 3 trial data: All you need to know | Covid

(1:52)

Bharat Biotech’s COVAXIN gets nod for phase 2/3 trials on 2-18 years old | Latest English News

(3:25)

Covaxin Shows Interim Efficacy Of 81% In Phase 3 Results: Bharat Biotech

(2:42)

Phase-1 Clinical Trials For Covaxin

(1:45)